false

Alexis Hobbins-White

Alexis Hobbins-White is an accomplished leader who plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. She specializes in early phase adaptive studies, particularly in immuno-oncology and advanced therapeutics. She has an MSc in Neuroscience and an MA in Biotechnology Law and Ethics.

• Read: The Collaborative CRO Partnership Model: Amplifying Your Team

  Clinical Trials

  The Collaborative CRO Partnership Model: Amplifying Your Team

  Feb 05, ‘26 | 10 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Navigating Complexity: Rescuing a Biomarker-Driven Breast Cancer Trial

  Clinical Trials - Oncology

  Navigating Complexity: Rescuing a Biomarker-Driven Breast Cancer Trial

  Jan 16, ‘26 | 4 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Case Study: Delivering Pivotal Data in Phase 3 R/R Multiple Myeloma

  Clinical Trials - Oncology

  Case Study: Delivering Pivotal Data in Phase 3 R/R Multiple Myeloma

  Dec 23, ‘25 | 4 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Case Study: Precise Data Management in Rare Liver Disease RNAi Trial

  Clinical Trials - Autoimmune

  Case Study: Precise Data Management in Rare Liver Disease RNAi Trial

  Dec 18, ‘25 | 8 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Phase 2-3 SCLC Case Study: Strategic Site Selection Drove Recruitment

  Clinical Trials - Oncology

  Phase 2-3 SCLC Case Study: Strategic Site Selection Drove Recruitment

  Dec 16, ‘25 | 2 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Clinical Trial Trends: Gene Therapy

  Clinical Trials - Gene Therapies

  Clinical Trial Trends: Gene Therapy

  Oct 29, ‘25 | 3 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Case Study: Biomarker-Driven Enrollment Using Notch Mutation Targeting

  Clinical Trials - Oncology

  Case Study: Biomarker-Driven Enrollment Using Notch Mutation Targeting

  Oct 07, ‘25 | 5 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Case Study: Global Phase 1-2 TCR Therapy in Advanced Solid Tumors

  Clinical Trials - Oncology

  Case Study: Global Phase 1-2 TCR Therapy in Advanced Solid Tumors

  Sep 30, ‘25 | 4 min read

  • 

    Alexis Hobbins-White

  Discover
• Read: Case Study: Phase 3 Ultra-Rare Pediatric Trial in Classic Galactosemia

  Case Study: Phase 3 Ultra-Rare Pediatric Trial in Classic Galactosemia

  Sep 23, ‘25 | 5 min read

  • 

    Alexis Hobbins-White

  Discover

Loading...

You've reach the end Back to top